Following a three-day bench trial in the matter on June 5-7, 2017 and after having considered the entire record in the case and the applicable law, the Court, through Trial
Continue Reading Judge Andrews Finds Plaintiff Proved Infringement of Asserted Claims of Patents-in-Suit Following Three-Day Bench Trial in Hatch-Waxman Action
no invalidity
Judge Sleet Finds Patent-In-Suit Is Not Invalid for Lack of Patentable Subject Matter
By Fox Rothschild LLP on
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Vanda Pharmaceuticals Inc., et al. v. Roxane Laboratories, Inc., Civil Action No. 13-1973-GMS (D.Del., August 25, 2016) (consolidated),…
Continue Reading Judge Sleet Finds Patent-In-Suit Is Not Invalid for Lack of Patentable Subject Matter
Judge Sleet Concludes that Defendants Did Not Prove Invalidity of Asserted Claim in ANDA Action
By Fox Rothschild LLP on
Following a four day bench trial in a consolidated ANDA action before The Honorable Gregory M. Sleet in Genzyme Corp., et al. v. Dr. Reddy’s Laboratories, Ltd., et al.,…
Continue Reading Judge Sleet Concludes that Defendants Did Not Prove Invalidity of Asserted Claim in ANDA Action
Chief Judge Stark Grants Plaintiffs’ Motion for Summary Judgment in Part as to No Invalidity of Patent-in-Suit
By Fox Rothschild LLP on
By Memorandum Opinion entered by The Honorable Leonard P. Stark in Fairchild Semiconductor Corp. v. Power Integrations, Inc., Civil Action No. 12-540-LPS (D.Del., May 4, 2015), the Court granted…
Continue Reading Chief Judge Stark Grants Plaintiffs’ Motion for Summary Judgment in Part as to No Invalidity of Patent-in-Suit
After Bench Trial, Judge Sleet Concludes that None of the Asserted Claims of the Patents-in-Suit Are Invalid Due to Obviousness
By Fox Rothschild LLP on
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Pfizer Inc., et al. v. Mylan Pharmaceuticals Inc., C.A. No. 10-528-GMS (D.Del., October 22, 2014), the Court, following…
Continue Reading After Bench Trial, Judge Sleet Concludes that None of the Asserted Claims of the Patents-in-Suit Are Invalid Due to Obviousness
After Bench Trial, Judge Sleet Concludes that Hospira’s Proposed Product Does Not Infringe the Patent-in-Suit Asserted by Abbvie
By Fox Rothschild LLP on
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Abbvie Inc. v. Hospira, Inc., C.A. No. 11-648- GMS (D.Del., October 24, 2014), the Court, following a two…
Continue Reading After Bench Trial, Judge Sleet Concludes that Hospira’s Proposed Product Does Not Infringe the Patent-in-Suit Asserted by Abbvie
Judge Robinson Grants Palm’s and Intermec’s Motions For Summary Judgment on Invalidity and Infringement in Part
By Fox Rothschild LLP on
By Memorandum Opinion entered by The Honorable Sue L. Robinson in Intermec Technologies Corp. v. Palm Inc., Civil Action No. 07-272-SLR (D.Del., September 15, 2011), the Court granted Defendant…